Theophylline sodium glycinate
Cat. No.: IBDI-434584
Theophylline (1,3-Dimethylxanthine) sodium glycinate is a potent phosphodiesterase (PDE) inhibitor, adenosine receptor antagonist, and histone deacetylase (HDAC) activator. Theophylline sodium glycinate inhibits PDE3 activity to relax airway smooth muscle. Theophylline sodium glycinate has anti-inflammatory activity by increase IL-10 and inhibit NF-κB into the nucleus. Theophylline sodium glycinate induces apoptosis. Theophylline sodium glycinate can be used for asthma and chronic obstructive pulmonary disease (COPD) research.
Product Details
| Target |
Adenosine Receptor | HDAC | Apoptosis | Interleukin Related | TNF Receptor |
| Molecular Weight |
278.22 |
| Synonyms |
1,3-Dimethylxanthine sodium glycinate, Theo-24 sodium glycinate |
| SMILES |
NCC(O)=O.O=C(N1C)C2=C(NC=N2)N(C)C1=O.[Na+] |
Storage & Handling
| Shipping |
Room temperature in continental US. May vary elsewhere. |
| Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| Regulatory Status |
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. |
! For research use only, not intended for any clinical use.